Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report) shares fell 10.7% on Monday . The company traded as low as $0.21 and last traded at $0.22. 2,151,500 shares traded hands during trading, an increase of 254% from the average session volume of 608,350 shares. The stock had previously closed at $0.25.
Lexaria Bioscience Price Performance
The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.01 and a current ratio of 8.52. The business’s 50-day moving average price is $0.22.
Lexaria Bioscience Company Profile
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries.
Featured Articles
- Five stocks we like better than Lexaria Bioscience
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Market Cap Calculator: How to Calculate Market Cap
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
